Larvol Delta - Targeting-GABAergic-dysfunction-in-schizophrenia-potassium-channel-modulation-KV312-as-treatment-targets-in-schizophrenia--imaging-and-electrophysiological-biomarker-findings-from-a-first-in-patient-study

AUT00206 - Autifony Therap

https://sirs.societyconference.com/conf/#sessions/conf10015

Judith Nottage; Stephen Kaar; Ilinca Angelescu; Tiago Reis Marques; Charles Large; Matthew Nour; Oliver Howes; John Hutchison; Alice Sharman; Anil Sajjala

Mar 10, 2023